GENITAL PRURITUS FEMALE

This adverse event was reported 324 times

GENITAL PRURITUS FEMALE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LANOLIN, PETROLATUM 1 0.0040
1 LANOLIN AND PETROLATUM 1 0.0038
2 ETONOGESTREL AND ETHINYL ESTRADIOL 34 0.0015
3 MEBENDAZOLE 1 0.0013
4 AMIFOSTINE 1 0.0012
5 WHITE PETROLATUM 1 0.0007
6 BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B 1 0.0006
7 BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE 1 0.0006
8 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 1 0.0005
9 CEFADROXIL 1 0.0005
See all drugs enriched for association with GENITAL PRURITUS FEMALE

GENITAL PRURITUS FEMALE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 1 0.0003
1 Estrogen [EPC] 47 0.0003
2 Progestin [EPC] 36 0.0001
3 Folate Analog [EPC] 5 0.0001
4 Vitamin A [EPC] 5 0.0001
5 Nicotinic Acid [EPC] 5 0.0001
6 Antidote [EPC] 5 0.0001
7 Potassium-sparing Diuretic [EPC] 1 0.0001
8 Parathyroid Hormone Analog [EPC] 8 0.0001
9 Non-Standardized Food Allergenic Extract [EPC] 5 0.0001
See all drug classes enriched for association with GENITAL PRURITUS FEMALE